Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
The Journal of Infectious Diseases|December 20, 2005
Preexposure to live Brugia malayi microfilariae alters the innate response of human dendritic cells to Mycobacterium tuberculosisKawsar R Talaat, Rachael E Bonawitz, Pilar Domenech, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosisEdward Mitre, Kawsar R Talaat, Michael R Sperling, et al.Expert Review of Vaccines|May 29, 2014
Development of live attenuated influenza vaccines against pandemic influenza strainsKathleen L Coelingh, Catherine J Luke, Hong Jin, et al.The American Journal of Tropical Medicine and Hygiene|October 9, 2008
Filarial/human immunodeficiency virus coinfection in urban southern IndiaKawsar R Talaat, Nagalingeswaran Kumarasamy, Soumya Swaminathan, et al.The Journal of Infectious Diseases|December 31, 2011
Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and genderSurender Khurana, Nitin Verma, Kawsar R Talaat, et al.Vaccine|February 3, 2019
The way forward for ETEC controlled human infection models (CHIMs)Kurt Hanevik, Wilbur H Chen, Kawsar R Talaat, et al.The American Journal of Tropical Medicine and Hygiene|January 8, 2011
A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasisRoshan Ramanathan, Kawsar R Talaat, Daniel P Fedorko, et al.Vaccine|January 30, 2016
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paperNeal A Halsey, Kawsar R Talaat, Adena Greenbaum, et al.Plos One|December 22, 2025
Experiences of participants in ETEC controlled human infection model studiesBettina Wunderlich, Kathryn Chang, Jessica L Schue, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2020
Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous LeishmaniasisJeanAnne M Ware, Elise M O'Connell, Thomas Brown, et al.Pageof 6